Robert L. Findling, M.D., M.B.A.
Recently, named the Leonard and Helen R. Stulman Professor in Child and Adolescent Psychiatry, Dr. Findling is the Director of Child and Adolescent Psychiatry and a Vice Chair in the Department of Psychiatry and Behavioral Sciences at Johns Hopkins. He is also the Vice President of Psychiatric Services and Research at the Kennedy Krieger Institute.
Dr. Findling is leading an effort to improve access to psychiatric care for young people, continuing to foster and integrate the faculties, services and research opportunities within the Division and working to broaden psychiatric research particularly in the area of prevention.
Dr. Findling came to Johns Hopkins in December of 2012. Before then, Dr. Findling was the Rocco L. Motto, M.D. Chair of Child and Adolescent Psychiatry at Case Western Reserve University School of Medicine. Dr. Findling was also the Director of the Division of Child and Adolescent Psychiatry at University Hospitals Case Medical Center.
Dr. Findling earned his undergraduate degree at Johns Hopkins University and went to medical school at the Medical College of Virginia. Dr. Findling then completed a triple board joint residency-training program in Pediatrics, Psychiatry, and Child and Adolescent Psychiatry at Mt. Sinai Hospital in New York City. He received his M.B.A. through a joint program, “Trium”, run by the London School of Economics, NYU Stern School of Business, and HEC Paris.
Dr. Findling’s research endeavors have focused on pediatric psychopharmacology and serious psychiatric disorders in the young. Dr. Findling has been honored with numerous awards and has received both national and international recognition as a clinical investigator.
Dr. Findling is currently the principal investigator on an NICHD contract that is comprehensively examining lithium in the treatment of pediatric mania. In addition, Dr. Findling is the principal investigator of an NIMH study that is assessing the longitudinal course of children with manic symptoms. He is also the site principal investigator of an NIMH-supported clinical trial that is examining the treatment of children with severe aggression. Dr. Findling’s research is also supported in part by the Stanley Medical Research Institute and the pharmaceutical industry.